# Hydrogen Sulfide: A Multitarget Therapeutic for Neuroinflammation in Neurodegenerative Diseases

**Authors:** Yuqing Zhang, Qiong Zhang, Li Yang, Yang Fan, Peng Zheng, Tiangui Liu, Xin Gao, Zhelei Ren, Xinpeng Wang, Bowen Zhou, Wei Liu, Tao Xin, Longguang Tang, Min Han

PMC · DOI: 10.34133/research.1107 · Research · 2026-02-18

## TL;DR

This paper reviews how hydrogen sulfide may help treat neurodegenerative diseases by reducing harmful brain inflammation.

## Contribution

The paper highlights H2S as a multitarget therapeutic for neuroinflammation and explores new clinical applications and mechanisms.

## Key findings

- H2S shows anti-inflammatory effects through modulation of glial activity and blood–brain barrier disruption.
- Preclinical data suggest H2S donors have a defined therapeutic window based on dose–exposure–response relationships.
- Spatial multiomics and microbiota-targeted approaches may improve H2S-based treatments.

## Abstract

Neurodegenerative diseases (NDDs) are characterized by the progressive degeneration of specific neuronal populations, remain incurable, and impose an escalating global health burden due to aging populations. While therapeutic options had expanded in recent years, their overall efficacy remained limited. Neuroinflammation emerged as a central factor in the pathogenesis of NDDs. Hydrogen sulfide (H2S), an endogenous gasotransmitter known for its potent anti-inflammatory properties, gained attention as a potential therapeutic agent. This review provided a comprehensive overview of the role of neuroinflammation in NDDs, elucidated the molecular mechanisms through which H2S exerted its anti-inflammatory effects, and discussed recent advancements and potential clinical applications. Special emphasis was placed on the modulation of glial activity, disruption of the blood–brain barrier, regulation of the gut–brain axis, and the interplay between mitochondria and inflammasomes. Furthermore, the review integrated preclinical data on dose–exposure–response relationships to define the therapeutic window of various H2S donors. It also explored the potential of spatial multiomics and microbiota-targeted approaches to facilitate more precise H2S-based interventions. These insights provide important scientific merit for elucidating the mechanisms of NDDs and hold urgent practical relevance for developing novel therapeutics to mitigate disease progression.

## Linked entities

- **Chemicals:** hydrogen sulfide (PubChem CID 402), H2S (PubChem CID 402)

## Full-text entities

- **Genes:** Cbs (cystathionine beta-synthase) [NCBI Gene 12411] {aka HIP4}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, APOE (apolipoprotein E) [NCBI Gene 348] {aka AD2, APO-E, ApoE4, LDLCQ5, LPG}, ARG1 (arginase 1) [NCBI Gene 383], KCNMA1 (potassium calcium-activated channel subfamily M alpha 1) [NCBI Gene 3778] {aka BKTM, CADEDS, IEG16, KCa1.1, LIWAS, MaxiK}, BDNF (brain derived neurotrophic factor) [NCBI Gene 627] {aka ANON2, BULN2}, SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, TST (thiosulfate sulfurtransferase) [NCBI Gene 7263] {aka RDS}, PRKAB1 (protein kinase AMP-activated non-catalytic subunit beta 1) [NCBI Gene 5564] {aka AMPK, HAMPKb}, STING1 (stimulator of interferon response cGAMP interactor 1) [NCBI Gene 340061] {aka ERIS, MITA, MPYS, NET23, SAVI, STING}, TICAM1 (TIR domain containing adaptor molecule 1) [NCBI Gene 148022] {aka IIAE6, MyD88-3, PRVTIRB, TICAM-1, TRIF}, MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, PGP (phosphoglycolate phosphatase) [NCBI Gene 283871] {aka AUM, G3PP, PGPase}, CLDN5 (claudin 5) [NCBI Gene 7122] {aka AWAL, BEC1, CPETRL1, TMDVCF, TMVCF}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, DAO (D-amino acid oxidase) [NCBI Gene 1610] {aka DAAO, DAMOX, OXDA}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, GDNF (glial cell derived neurotrophic factor) [NCBI Gene 2668] {aka ATF, ATF1, ATF2, HFB1-GDNF, HSCR3}, SQOR (sulfide quinone oxidoreductase) [NCBI Gene 58472] {aka CGI-44, PRO1975, SQR, SQRDL}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, BCHE (butyrylcholinesterase) [NCBI Gene 590] {aka BCHED, CHE1, CHE2, E1}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, S100B (S100 calcium binding protein B) [NCBI Gene 6285] {aka NEF, S100, S100-B, S100beta}, PTGS2 (prostaglandin-endoperoxide synthase 2) [NCBI Gene 5743] {aka COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2}, Psen1 (presenilin 1) [NCBI Gene 19164] {aka Ad3h, PS-1, PS1, S182}, CTH (cystathionine gamma-lyase) [NCBI Gene 1491] {aka CGL, CSE}, NQO1 (NAD(P)H quinone dehydrogenase 1) [NCBI Gene 1728] {aka DHQU, DIA4, DTD, NMOR1, NMORI, QR1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, OCLN (occludin) [NCBI Gene 100506658] {aka BLCPMG, PPP1R115, PTORCH1}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, Cth (cystathionine gamma lyase) [NCBI Gene 107869] {aka 0610010I13Rik, CGL, CSE, Cys3}, CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, CAV1 (caveolin 1) [NCBI Gene 857] {aka BSCL3, CGL3, LCCNS, MSTP085, PPH3, VIP21}, COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, PKM (pyruvate kinase M1/2) [NCBI Gene 5315] {aka CTHBP, HEL-S-30, OIP3, PK3, PKM2, TCB}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, PINK1 (PTEN induced kinase 1) [NCBI Gene 65018] {aka BRPK, PARK6}, PLA2G7 (phospholipase A2 group VII) [NCBI Gene 7941] {aka LDL-PLA2, LP-PLA2, PAFAD, PAFAH}, MAVS (mitochondrial antiviral signaling protein) [NCBI Gene 57506] {aka CARDIF, IPS-1, IPS1, VISA}, COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}, RELA (RELA proto-oncogene, NF-kB subunit) [NCBI Gene 5970] {aka AIF3BL3, CMCU, NFKB3, p65}, SLC2A1 (solute carrier family 2 member 1) [NCBI Gene 6513] {aka CSE, DYT17, DYT18, DYT9, EIG12, GLUT}, SUOX (sulfite oxidase) [NCBI Gene 6821], PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, PRL (prolactin) [NCBI Gene 5617] {aka GHA1, pPRL}, MYD88 (MYD88 innate immune signal transduction adaptor) [NCBI Gene 4615] {aka IMD68, MYD88D, WM1}, ABCB1 (ATP binding cassette subfamily B member 1) [NCBI Gene 5243] {aka ABC20, CD243, CLCS, ENPAT, GP170, MDR1}, IKBKB (inhibitor of nuclear factor kappa B kinase subunit beta) [NCBI Gene 3551] {aka IKK-2, IKK-beta, IKK2, IKKB, IMD15, IMD15A}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, NFKBIA (NFKB inhibitor alpha) [NCBI Gene 4792] {aka EDAID2, IKBA, MAD-3, NFKBI}, MPST (mercaptopyruvate sulfurtransferase) [NCBI Gene 4357] {aka MST, TST2, TUM1}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, HTT (huntingtin) [NCBI Gene 3064] {aka HD, IT15, LOMARS}, CBS (cystathionine beta-synthase) [NCBI Gene 875] {aka HIP4}
- **Diseases:** aggregation (MESH:D020914), ischemia (MESH:D007511), neuronal dysfunction (MESH:D009461), neurofibrillary (MESH:D055956), Inflammatory (MESH:D007249), NDDs (MESH:D019636), metabolic disturbances (MESH:D024821), mitochondrial dysfunction (MESH:D028361), PD (MESH:D010300), neurotoxic (MESH:D020258), AD (MESH:D000544), HD (MESH:D006816), BBB (MESH:C536830), Neuroinflammation (MESH:D000090862), CNS injury (MESH:D002493), edema (MESH:D004487), neuronal injury (MESH:D009410), amyloid (MESH:C000718787), hyperbilirubinemia (MESH:D006932), amyloid plaques (MESH:D058225), cognitive impairment (MESH:D003072), dopaminergic dysfunction (MESH:D009422), ALS (MESH:D000690), death (MESH:D003643), H2S deficiency (MESH:D007153), acute CNS injury (MESH:D001930), neurovascular unit (MESH:D013901), COVID-19 (MESH:D000086382), cytotoxic (MESH:D064420), proteinopathies (MESH:D057165)
- **Chemicals:** 6-OHDA (MESH:D016627), metformin (MESH:D008687), 3-MP (MESH:C008366), indoles (MESH:D007211), ursolic acid (MESH:C005466), NO (MESH:D009569), succinate (MESH:D019802), methionine (MESH:D008715), ACS84 (MESH:C583845), polysulfide (MESH:C032915), sulfide (MESH:D013440), TPP+ (MESH:C016136), sulfate (MESH:D013431), Na2S (MESH:C033479), memantine (MESH:D008559), CO (MESH:D002248), diallyl trisulfide (MESH:C042577), carbon (MESH:D002244), tricarboxylic acid (MESH:D014233), ATP (MESH:D000255), NaHS (MESH:C025451), L-cysteine (MESH:D003545), lipid (MESH:D008055), 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MESH:D015632), persulfides (MESH:C051552), CoQ (MESH:D014451), GYY4137 (MESH:C529376), PLP (MESH:D011732), tryptophan (MESH:D014364), CaS (MESH:D002118), short-chain fatty acids (MESH:D005232), 3-NP toxin (-), L-DOPA (MESH:D007980), H2S (MESH:D006862), sulfur (MESH:D013455), K+ (MESH:D011188), thiosulfate (MESH:D013885), thiol (MESH:D013438), amino acid (MESH:D000596), homocysteine (MESH:D006710), TCA (MESH:D014238)
- **Species:** Desulfovibrio (genus) [taxon 872], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** G93A

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914062/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914062/full.md

## References

176 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914062/full.md

---
Source: https://tomesphere.com/paper/PMC12914062